Objectively tracking lesions in dermatology clinical trials

White Paper

March 4, 2019
Objectively tracking lesions in dermatology clinical trials
There is an increasing need for objectivity in mapping and analyzing of lesions to create confidence in trial findings, reproducibility and translation to clinical practice for dermatology sponsors, regulators and clinicians. This paper examines evolving diagnostic practices coupled with advancing technology and their application to reduce subjectivity in dermatology clinical trials.

Learning Objectives:
  • Learn about the challenges for objective diagnosis and evaluation of patient lesions in clinical practice and trials
  • Review current tools and scoring available to measure dermatological lesions
  • Understand the consideration of the new technologies when developing dermatology trial protocols